Search Orphan Drug Designations and Approvals
-
Generic Name: | IgG4 Fc linked recombinant human AAT (alpha-1 antitrypsin) |
---|---|
Date Designated: | 03/02/2022 |
Orphan Designation: | Treatment of Congenital Alpha-1 Antitrypsin Deficiency (AATD) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Sanofi AATD Inc. 450 Water Street Cambridge, Massachusetts 01241 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-